Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 595.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,780 shares of the company’s stock after acquiring an additional 29,778 shares during the quarter. Hsbc Holdings PLC’s holdings in Acadia Healthcare were worth $2,338,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares in the last quarter. Mather Group LLC. acquired a new position in shares of Acadia Healthcare during the 1st quarter worth about $48,000. nVerses Capital LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $95,000. Innealta Capital LLC acquired a new stake in shares of Acadia Healthcare during the 2nd quarter worth about $164,000. Finally, Capstone Investment Advisors LLC purchased a new stake in Acadia Healthcare during the fourth quarter worth approximately $204,000.

Analyst Ratings Changes

Several equities analysts have commented on ACHC shares. Barclays dropped their price target on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a research note on Thursday, August 1st. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Monday, August 19th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $87.44.

Acadia Healthcare Trading Down 0.1 %

NASDAQ:ACHC opened at $75.66 on Friday. Acadia Healthcare Company, Inc. has a 12-month low of $62.04 and a 12-month high of $87.77. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock’s 50 day simple moving average is $74.26 and its 200-day simple moving average is $71.84. The firm has a market cap of $7.02 billion, a P/E ratio of -540.43, a PEG ratio of 2.19 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. During the same period in the previous year, the company posted $0.92 EPS. Acadia Healthcare’s revenue was up 8.8% compared to the same quarter last year. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.